Yunita Lim

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications”.

PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications

Neuro-Oncology(2022)10.1093/neuonc/noac064

N/A

0DataRank · unranked

80 citations

Anupam Kumar, Yalan Zhang, Albert S Wang, Katharine Chen, Yunita Lim +10 more

CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2830

N/A

0DataRank · unranked

66 citations

Esraa Mohamed, Schuyler Tong, Katharine Chen, Joydeep Mukherjee, Yunita Lim +12 more

Data from CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma

(2023)10.1158/1078-0432.c.6531363.v1

N/A

0DataRank · unranked

1 citations

Esraa Mohamed, Schuyler Tong, Katharine Chen, Joydeep Mukherjee, Yunita Lim +12 more

Data from CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma

(2023)10.1158/1078-0432.c.6531363

N/A

0DataRank · unranked

0 citations

Esraa Mohamed, Schuyler Tong, Katharine Chen, Joydeep Mukherjee, Yunita Lim +12 more

Quantitative Assessment of Preanalytic Variables on Clinical Evaluation of PI3/AKT/mTOR Signaling Activity in Diffuse Glioma

Modern Pathology(2024)10.1016/j.modpat.2024.100488

N/A

0DataRank · unranked

3 citations

Esraa Mohamed, Viva Voong, Stephanie Hilz, Marisa Lafontaine, Anny Shai +11 more